Antivirals Flashcards
Acyclovir
Indications?
Dosage Forms?
Zovirax
* Buccal form should be avoided in patients with a milk protein allergy
* BUN and SCr will be monitored (with prolonged therapy)
* Patients should stop taking med at least 24 hours before, and 14 days after, varicella vaccine
* Should be avoided in patients who also take kidney toxic drugs (lithium, mathotrexate, etc.)
Viral infections
Injectable, oral solid, liquid, topical
Docosanol
Indications?
Dosage Forms?
Abreva
* Should not be used in kids under 12
Herpes (cold sores)
Topical
Famciclovir
Indications?
Dosage Forms?
Famvir
* BUN and SCr will be monitored (with prolonged therapy)
* Patients should stop taking med at least 24 hours before, and 14 days after, varicella vaccine
Viral infections
Oral solid
Foscarnet
Indications?
Dosage Forms?
Foscavir
* BUN, CBC, ECG, and SCr will be monitored (with prolonged therapy)
* May cause electrolyte imbalances
* Must be infused slowly
Viral infections
Injectable
Ganciclovir
Indications?
Dosage Forms?
Cytovene
* BUN, CBC, LFTs, and SCr will be monitored (with prolonged therapy)
* May cause bone marrow suppression
* Must be infused slowly (with injectable)
* Patients should stop taking at least 7 days before starting cidofovir
Viral infections
Injectable, ophthalmic
Imiquimod
Indications?
Dosage Forms?
Aldara
* Can weaken barrier contraceptive devices (condoms, etc) when applied in the pubic area
Genital herpes
Topical
Oseltamivir
Indications?
Dosage Forms?
Tamiflu
* Must be started within 48 hours of flu symptoms
* Patients should stop taking med at least 2 weeks before, or 48 hours after, intranasal LAIV
Influenza
Oral powder (suspension), oral solid
Remdesivir
Indications?
Dosage Forms?
Veklury
* Should be avoided in patients who take chloroquine or hydrochloroquine
COVID-19
Injectable
Valacyclovir
Indications?
Dosage Forms?
Valtrex
* BUN and SCr will be monitored (with prolonged therapy)
* Patient should stop taking med at least 24 hours before, and 14 days after, varicella vaccine
* Should be avoided in patients who take kidney toxic drugs (lithium, methotrexate, etc.)
Viral infections
Oral solid
Valganciclovir
Indications?
Dosage Forms?
Valcyte
* BUN, CBC, and SCr will be monitored (with prolonged therapy)
* May cause bone marrow suppression
* NIOSH med
* Should be avoided in patients who take kidney toxic drugs (lithium, methotrexate, etc.)
Viral infections
Oral solid, oral powder (suspension)
Zanamivir
Indications?
Dosage Forms?
Relenza
* Must be started within 48 hours of flu symptoms
* Patients should stop taking med at least 2 weeks before, or 48 hours after, intranasal LAIV
Influenza
Inhalation powder
Cabotegravir
Indications?
Dosage Forms?
Apretude
* High-alert med
* Must be injected by a healthcare provider
* Patient must be HIV negative before starting therapy
HIV PrEP
Injectable, oral solid
Emtricitabine/tenofovir alafenamide
Indications?
Dosage Forms?
Descovy
* BUN and SCr will be monitored
* High-alert med
* Patient must be HIV negative before starting therapy
* Should use with caution if pregnant or breastfeeding
HIV PrEP
Oral solid
Emtricitabine/tenofovir disoproxil
Indications?
Dosage Forms?
Truvada
* BUN and SCr will be monitored
* High-alert med
* Patient must be HIV negative before starting therapy
HIV PrEP, HIV PEP
Oral solid